This Ridiculously Cheap Growth Stock Could Make You a Millionaire

Hormel Foods is being positioned as a higher-margin branded protein company, with five straight quarters of organic net sales growth and high-single-digit growth in Foodservice and International. The company has a 60-year dividend growth streak and a roughly 4% yield, while ongoing divestitures like its whole-bird turkey business are narrowing exposure to lower-margin commodity proteins. The article argues that at about $20 per share, valuation is near early-2010s lows and could support strong long-term compounding if growth and margin improvement continue.

Analysis

The market is still treating HRL like a low-quality input-cost hostage, but the important shift is that management is actively shrinking the part of the business where duration of inflation matters most. That matters because once you remove the most commoditized earnings streams, the remaining portfolio should exhibit better gross margin stability and a lower earnings beta to feed costs than the headline P&L suggests. If this mix shift continues, the multiple can rerate before the full profit rebound shows up in consensus, because branded-food investors typically pay up for visibility long before growth accelerates.

The bigger second-order effect is channel mix. Foodservice recovery is not just incremental revenue; it is a proof point that HRL’s pricing and distribution leverage still work in a higher-margin channel that can offset weak retail volumes. That also pressures smaller branded and private-label peers that lack the same breadth of SKU placement and export reach, especially if HRL keeps pruning non-core assets and redeploying capital into core branded proteins and snacks. The export growth in branded items suggests international is becoming a real earnings lever rather than a side business, which could lift the long-run organic growth ceiling by 100-200 bps if sustained.

Consensus is likely underestimating how much of the bear case is backward-looking. If raw materials normalize, the operating leverage from a cleaner mix can hit quickly over the next 2-4 quarters, while the dividend floor reduces downside for patient capital. The risk is that retail softness persists and the company becomes too dependent on foodservice and international to carry the model; if commodity inflation re-accelerates, the rerating case stalls and the stock can remain value-trapped for another 6-12 months.

The cleanest setup is not an aggressive outright bet, but a valuation/recovery trade with a defensive carry overlay. The stock can work from here even without heroic growth assumptions if the market starts pricing it as a branded consumer staple with modest earnings expansion rather than a protein processor with cyclical margins.

Key Decisions for Investors

• Long HRL as a 6-12 month valuation recovery trade; target a rerating toward historical branded-staples multiples if organic sales stays positive and commodity pressure eases. Use a staggered entry on weakness given the risk of another soft retail print.
• Write cash-secured puts on HRL 3-6 months out at strikes below current support to monetize elevated pessimism while waiting for margin normalization; attractive if you want dividend carry plus a lower entry basis.
• Pair long HRL / short a more commodity-exposed packaged-protein peer if available in your book, expressing the view that mix improvement and divestitures will reduce earnings volatility faster than the sector expects.
• For event risk, avoid chasing ahead of near-term earnings; instead, look to add after a downside reaction if management confirms continued foodservice/international growth and no deterioration in gross margin trajectory.
• If you need a defensive income sleeve, HRL is a reasonable substitute for lower-quality yield names with weaker balance sheets; the risk/reward improves materially if the stock stays near multi-year valuation lows while the dividend compounds.